Department of Pharmacology and Toxicology, Faculty of Pharmacy, Comenius University, Bratislava, Slovakia.
Eur J Pharmacol. 2009 Oct 1;619(1-3):85-91. doi: 10.1016/j.ejphar.2009.08.003. Epub 2009 Aug 14.
Chronic treatment with several antihypertensive agents, including calcium channel blockers, may interfere with remodeling of large arteries and increased arterial stiffness. We hypothesize that even a short, seven-day administration of calcium channel blockers might alter an aortic remodeling in spontaneously hypertensive rat (SHR). Male SHR and normotensive WKY rats (n=14 each) were treated by either vehicle, vasculoselective calcium channel blocker nifedipine (1mg/kg/day) or cardiac/vascular calcium channel blockers diltiazem (5mg/kg/day) or verapamil (4 mg/kg/day, n=6 for each treatment) subcutaneously twice daily for seven days. Additional SHR rats were randomized for termination 24, 72 or 120 h (n=5 each) after the withdrawal of nifedipine. Systolic blood pressure was measured by tail cuff and thoracic aorta was collected for histomorphometric and functional analysis including acetylcholine-induced endothelium-dependent relaxation. Seven-day administration of diltiazem and nifedipine, but not verapamil decreased blood pressure in SHR. All drugs significantly attenuated abnormal aortic wall thickness, cross-sectional area and media-to-lumen ratio, but only nifedipine improved impaired endothelium-dependent relaxation. Following the withdrawal of nifedipine, all measured parameters returned back to control SHR values within 72 h. Seven-day treatment with distinct calcium channel blockers attenuates hypertensive remodeling of aorta, which might be, in case of nifedipine, reactivated even by a very short withdrawal of the drug. Therefore, vasculoprotection by calcium channel blockers is not restricted to a prolonged blood pressure modulation, but occurs rapidly. These findings could be relevant for an intervention in augmented vascular stiffness and related cardiovascular risk.
慢性使用多种降压药物,包括钙通道阻滞剂,可能会干扰大动脉的重构和动脉僵硬度的增加。我们假设,即使是短期的,七天的钙通道阻滞剂治疗也可能改变自发性高血压大鼠(SHR)的主动脉重构。雄性 SHR 和正常血压 WKY 大鼠(每组 14 只)分别接受vehicle、血管选择性钙通道阻滞剂硝苯地平(1mg/kg/天)、心脏/血管钙通道阻滞剂地尔硫卓(5mg/kg/天)或维拉帕米(4mg/kg/天,每组 6 只)皮下注射,每天两次,共七天。另外的 SHR 大鼠随机分为硝苯地平停药后 24、72 或 120 小时(每组 5 只)终止组。通过尾套测量收缩压,并收集胸主动脉进行组织形态学和功能分析,包括乙酰胆碱诱导的内皮依赖性舒张。七天的地尔硫卓和硝苯地平治疗可降低 SHR 的血压,但维拉帕米没有。所有药物均显著减轻主动脉壁厚度、横截面积和中腔比的异常,但只有硝苯地平改善了受损的内皮依赖性舒张。硝苯地平停药后,所有测量参数在 72 小时内恢复到对照 SHR 值。不同的钙通道阻滞剂治疗 7 天可减轻高血压大鼠的主动脉重构,硝苯地平停药后,即使停药很短时间,这种重构也可能重新激活。因此,钙通道阻滞剂的血管保护作用不仅限于长期的血压调节,而是迅速发生。这些发现可能与增强血管僵硬和相关心血管风险的干预有关。